TIZANIDINE
NDC 84386-023, TIZANIDINE, tablet, from Aurobindo Pharma Limited.
- Product NDC
- 84386-023
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076282
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/84386-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 84386-023-77 | 84386002377 | 150 TABLET in 1 BOTTLE (84386-023-77) |
| 84386-023-99 | 84386002399 | 1000 TABLET in 1 BOTTLE (84386-023-99) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7ce17c02-7f1f-4d52-8b6f-52e385e12239
Use it
Look up 84386-023 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/84386-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 84386-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.